Jump Trading’s Aratana Therapeutics, Inc. PETX Stock Holding History

Jump Trading’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-18,300	Closed	-$66K	–	697
2019 Q1	$66K	Buy	+18,300	New	+$79.3K	0.02%	516

Other funds holding PETX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Jump Trading's PETX Position: Q2 2019 in Review

Jump Trading sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2019, closing a stake of 18,300 shares — an estimated $66K sold.

Jump Trading first reported a position in PETX in Q1 2019 and held it in 1 quarter. The position peaked at $66K in Q1 2019. 103 funds tracked by Wall St. Rank hold PETX as of Q2 2019.

Jump Trading reported no remaining Aratana Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 18,300 Aratana Therapeutics, Inc. shares in Q2 2019, an estimated $66K.
Jump Trading first reported a position in Aratana Therapeutics, Inc. in Q1 2019 and held it in 1 quarter.
Jump Trading's Aratana Therapeutics, Inc. position peaked at $66K in Q1 2019.
103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.